中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2014年
8期
12-13,14
,共3页
透明晶状体超声乳化术%高度近视
透明晶狀體超聲乳化術%高度近視
투명정상체초성유화술%고도근시
Transparent lens phacoemulsification%High myopia
目的:探讨透明晶状体超声乳化联合人工晶状体植入术治疗老年高度近视的安全性及临床疗效的观察。方法对60只眼已行老年高度近视白内障超声乳化术眼的对侧眼即透明晶状体眼进行透明角膜切口行超声乳化联合人工晶体植入术,患者年龄为(62~76)岁,平均(54±4.64)岁,平均等效球镜度数为(8.23±4.83)D,平均眼轴长度(29.44±2.06)mm,植入人工晶体度数为(6.23±3.83)D,随访12~24个月。结果术后60只眼最佳矫正视力均超过术前最佳矫正视力,术后裸眼视力达到或超过0.5者24只眼(40.00%),52只眼(86.67%)予矫正屈光度±1.0 D以内,术后平均屈光度为(8.24±4.84)D,术中未发生并发症,术后12~24个月随访,其中,4只眼(6.67%)发生后发障,术后未发生角膜水肿、人工晶状体偏位、视网膜裂孔形成、视网膜脱离、黄斑出血等严重的并发症。结论透明晶状体超声乳化联合人工晶状体植入治疗老年高度近视与目前的角膜屈光手术相比,可能更适合戴镜不能矫治高度近视眼患者,具有安全、有效、并发症少、术后视力好等优点,其远期效果需长期随访和观察。
目的:探討透明晶狀體超聲乳化聯閤人工晶狀體植入術治療老年高度近視的安全性及臨床療效的觀察。方法對60隻眼已行老年高度近視白內障超聲乳化術眼的對側眼即透明晶狀體眼進行透明角膜切口行超聲乳化聯閤人工晶體植入術,患者年齡為(62~76)歲,平均(54±4.64)歲,平均等效毬鏡度數為(8.23±4.83)D,平均眼軸長度(29.44±2.06)mm,植入人工晶體度數為(6.23±3.83)D,隨訪12~24箇月。結果術後60隻眼最佳矯正視力均超過術前最佳矯正視力,術後裸眼視力達到或超過0.5者24隻眼(40.00%),52隻眼(86.67%)予矯正屈光度±1.0 D以內,術後平均屈光度為(8.24±4.84)D,術中未髮生併髮癥,術後12~24箇月隨訪,其中,4隻眼(6.67%)髮生後髮障,術後未髮生角膜水腫、人工晶狀體偏位、視網膜裂孔形成、視網膜脫離、黃斑齣血等嚴重的併髮癥。結論透明晶狀體超聲乳化聯閤人工晶狀體植入治療老年高度近視與目前的角膜屈光手術相比,可能更適閤戴鏡不能矯治高度近視眼患者,具有安全、有效、併髮癥少、術後視力好等優點,其遠期效果需長期隨訪和觀察。
목적:탐토투명정상체초성유화연합인공정상체식입술치료노년고도근시적안전성급림상료효적관찰。방법대60지안이행노년고도근시백내장초성유화술안적대측안즉투명정상체안진행투명각막절구행초성유화연합인공정체식입술,환자년령위(62~76)세,평균(54±4.64)세,평균등효구경도수위(8.23±4.83)D,평균안축장도(29.44±2.06)mm,식입인공정체도수위(6.23±3.83)D,수방12~24개월。결과술후60지안최가교정시력균초과술전최가교정시력,술후라안시력체도혹초과0.5자24지안(40.00%),52지안(86.67%)여교정굴광도±1.0 D이내,술후평균굴광도위(8.24±4.84)D,술중미발생병발증,술후12~24개월수방,기중,4지안(6.67%)발생후발장,술후미발생각막수종、인공정상체편위、시망막렬공형성、시망막탈리、황반출혈등엄중적병발증。결론투명정상체초성유화연합인공정상체식입치료노년고도근시여목전적각막굴광수술상비,가능경괄합대경불능교치고도근시안환자,구유안전、유효、병발증소、술후시력호등우점,기원기효과수장기수방화관찰。
Objective To observe the clinical effect and safety of transparent lens phacoemulsification combined with intraocular lens implantation in the treatment of elderly patients with high myopia. Methods On 60 eyes with high myopia has been in senile cataract phacoemulsification contralateral eye eye eye lens that was transparent transparent corneal incision phacoemulsification and intraocular lens implantation, patients aged 62~76, the average (54±4.64), the average spherical equivalent degree of (8.23±4.83)D, the average axial length (29.44±2.06), implantation of intraocular lens power was (6.23±3.83)D, during the follow-up of 12-24 months. Results After operation, 60 eyes of best corrected visual acuity of more than preoperative best corrected visual acuity, postoperative uncorrected visual acuity reached or exceeded 0.5 in 24 eyes (40.00%), in 52 eyes (86.67%) treated with internal corrective diopter ±1 D, the average refractive surgery is (8.24±4.84)D, No complications occurred during the operation, followed up for 12~24 months, after operation, 4 eyes (6.67%) after cataract, severe complications did not occur without postoperative corneal edema, intraocular lens shift, the formation of retinal hole, retinal detachment. Conclusion Transparent lens phacoemulsification with intraocular lens implantation therapy in elderly high myopia compared with current corneal refractive surgery, may be more suitable for patients with high myopia wear glasses can't correction, is a safe, effective, less complications, postoperative visual acuity is good, its long-term effect needs long-term follow-up observation.